Pseudotumor Cerebri: Clinical Trials

51 trials for Pseudotumor Cerebri, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 11 recruiting, 11 unknown, 6 active not recruiting. 22 Not applicable, 6 Phase 3, 3 Phase 4, 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 5, Recruiting 5, Unknown 4, Active not recruiting 3, Not yet recruiting 2, Terminated 2, Suspended 1
Phase 36Terminated 2, Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 43Completed 1, Recruiting 1, Unknown 1
Phase 22Completed 2
Early Phase 11Completed 1
Phase 11Completed 1

Follow Pseudotumor Cerebri: new trials by email Literature Review of Pseudotumor Cerebri trials Research Report on Pseudotumor Cerebri

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stenting Of Symptomatic Cerebral siNus stenosIs With the laserCut Self-expanding SILANCE Stent
SILANCE Stent Implantation - Idiopathic Intracranial Hypertension (IIH)
Not applicableNot yet recruitingAcandis GmbH992026-09-012026-05-01
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Tirzepatide, Tirzepatide Placebo - Idiopathic Intracranial Hypertension (IIH)
Phase 4RecruitingDuke University602026-08-252026-09-15
Eptinezumab for Chronic Headache in Idiopathic Intracranial Hypertension
Eptinezumab, Placebo - Idiopathic Intracranial Hypertension (IIH)
Phase 3Not yet recruitingRigmor Højland Jensen962026-06-222026-06-12
Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management
lumbo-peritoneal shunt, Conservative Management: Centered on lifestyle modifications for weight reduction, alongside targeted medical therapies including carbonic anhydrase inhibitors (e.g., acetazolamide) and/or topiramate. - Idiopathic Intracranial Hypertension
Not applicableActive not recruitingSohag University302026-06-012026-07-21
Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide
Acetazolamide, Stent (Tentos 4F or Precise ProRX) - Idiopathic Intracranial Hypertension (IIH)
Not applicableRecruitingUniversity Hospital, Montpellier1142026-01-052026-03-06
Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase
Best medical care, Intervention (stenting) - Idiopathic Intracranial Hypertension (IIH)
Not applicableRecruitingUniversity Hospital, Montpellier1142025-09-192025-10-03
Advanced Neuroimaging in Idiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension (IIH), Glymphatic System
RecruitingThomas Jefferson University302025-03-032025-05-02
Dural Venous Sinus Stent in Idiopathic Intracranial Hypertension
Dural venous sinus stenting - Idiopathic Intracranial Hypertension (IIH)
Not applicableNot yet recruitingAssiut University402025-03-012025-02-18
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
ALS (Amyotrophic Lateral Sclerosis), FTD
Active not recruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta2302025-02-272026-08-28
Prospective Ocular Imaging for Intracranial Pressure Evaluation
Idiopathic Intracranial Hypertension, Intracranial Pressure Increase
RecruitingKing's College Hospital NHS Trust1602025-01-102025-08-03
Pseudotumor Cerebri Headache Ten Years Outcome
Pseudotumor Cerebri
UnknownBnai Zion Medical Center1002024-07-012024-09-03
BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment
Weight loss without pharmacotherapy - Idiopathic Intracranial Hypertension (IIH)
RecruitingUniversity of Valencia252024-06-272026-04-22
ICP & Outflow Study
Lumbar puncture - Eye Change, Idiopathic Intracranial Hypertension
UnknownGuy's and St Thomas' NHS Foundation Trust662024-06-012024-06-12
Current Treatment Methods of Idiopathic Intracranial Hypertension
Lumbar puncture - IIH - Idiopathic Intracranial Hypertension
UnknownAssiut University642024-06-012024-04-09
Ocular Perfusion in Patients With Idiopathic Intracranial Hypertension
Lumbar puncture and administration of medication - Idiopathic Intracranial Hypertension
UnknownMedical University of Vienna482024-05-282024-08-30
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
Semaglutide, Low calorie diet - Idiopathic Intracranial Hypertension
Phase 3UnknownCapital Medical University742024-05-012024-04-12
Biomarkers in the Etiology of Idiopathic Intracranial Hypertension
Blood punction, Central blood sampling, Intracranial pressure measurement - Idiopathic Intracranial Hypertension
Not applicableUnknownUniversity Hospital, Montpellier602023-11-272024-05-28
IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost Effectiveness
CSF shunt, DVSS - IIH - Idiopathic Intracranial Hypertension
Not applicableRecruitingUniversity of Birmingham802023-07-182026-02-27
MR Lymphatic Imaging in Idiopathic Intracranial Hypertention
3T MRI with Gadobutrol injection - Idiopathic Intracranial Hypertension
Not applicableCompletedInstitut National de la Santé Et de la Recherche Médicale, France402023-03-102026-10-08
Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)
Stent Implantation, Acetazolamide-based medical therapy, Weight loss - Idiopathic Intracranial Hypotension, Venous Sinus Stenosis
Phase 3RecruitingBeijing Tiantan Hospital742023-02-162026-02-10

Showing 20 of 51. Sign in to see all of them.

Narrower conditions

Intracranial Hypertension (9)  ·  Papilledema (8)  ·  Headache (7)  ·  Tinnitus (4)  ·  Vision Disorders (4)  ·  Hydrocephalus (3)  ·  Obesity (3)  ·  Headache Disorders (2)  ·  Hydrocephalus, Normal Pressure (2)  ·  Weight Loss (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Blindness (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Infections (1)

Broader conditions

Brain Diseases (51)  ·  Central Nervous System Diseases (51)  ·  Nervous System Diseases (50)  ·  Intracranial Hypertension (42)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (12)  ·  Eye Diseases (10)  ·  Neurologic Manifestations (10)  ·  Cranial Nerve Diseases (8)  ·  Optic Nerve Diseases (8)  ·  Pain (7)  ·  Sensation Disorders (7)  ·  Nutritional and Metabolic Diseases (5)  ·  Body Weight (4)  ·  Ear Diseases (4)

Interventions

Acetazolamide (6)  ·  Spinal Puncture (5)  ·  Stents (3)  ·  semaglutide (2)  ·  2-(1-(5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl)-3-piperidyl)acetic acid (1)  ·  Acetaminophen (1)  ·  Aspirin (1)  ·  Bariatric Surgery (1)  ·  Caloric Restriction (1)  ·  Codeine (1)  ·  Diagnostic Imaging (1)  ·  Diuretics (1)  ·  Drug Therapy (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Ibuprofen (1)

Sponsors

University Hospital, Montpellier (3)  ·  University of Birmingham (3)  ·  Assiut University (2)  ·  Danish Headache Center (2)  ·  Integra LifeSciences Corporation (2)  ·  Rigmor Højland Jensen (2)  ·  Acandis GmbH (1)  ·  Al-Azhar University (1)  ·  Beijing Tiantan Hospital (1)  ·  Bnai Zion Medical Center (1)  ·  Capital Medical University (1)  ·  Duke University (1)  ·  Ege University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Fayoum University (1)

Countries

United States (16)  ·  Egypt (5)  ·  France (5)  ·  United Kingdom (5)  ·  Canada (4)  ·  Denmark (3)  ·  Germany (3)  ·  Israel (3)  ·  Spain (2)  ·  Switzerland (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  China (1)  ·  Italy (1)

Top investigators

Michael Wall, MD (2)  ·  Alexa N Bramall, MD (1)  ·  Alexandra Sinclair, MBChB (1)  ·  Alexandra Sinclair, MbChb PhD (1)  ·  Alice Y Chang, MD (1)  ·  Andrew W Lawton, MD (1)  ·  Athos Patsalides, MD (1)  ·  Athos Patsalides, MD, MPH (1)  ·  Dagmar Beier, M.D., Ph.D. (1)  ·  Dapeng Mo, MD (1)  ·  Felipe C Albuquerque, MD (1)  ·  Hsiangkuo Yuan, MD PhD (1)  ·  Jai Shankar, MD (1)  ·  John J Chen, M.D., Ph.D. (1)

Results publications

PMID 12455560, PMID 28255904, PMID 36240084, PMID 12670853, PMID 14872049, PMID 15230741, PMID 16816807, PMID 16997419, PMID 17384377, PMID 18275454, PMID 18477382, PMID 18495051, PMID 19167786, PMID 1931224, PMID 21323404, PMID 21505900, PMID 21523461, PMID 21680652, PMID 21769456, PMID 21799038, PMID 22204998, PMID 22258019, PMID 22944553, PMID 23883223, PMID 24756302, PMID 24756514, PMID 24781936, PMID 25370510, PMID 25370513, PMID 25859134, PMID 26024112, PMID 26146651, PMID 26335066, PMID 2653341, PMID 26618282, PMID 26778344, PMID 26934136, PMID 27556959, PMID 27694262, PMID 27886896, PMID 28130349, PMID 28187976, PMID 28492874, PMID 28923789, PMID 28963303, PMID 30219791, PMID 3156890, PMID 33098644, PMID 33900360, PMID 34420064

NIH funding

U10EY025990 (2), 2025 (1), U10EY017281 (1), U10EY017387 (1)